Bell Investment Advisors’s Amicus Therapeutics FOLD Stock Holding History

Bell Investment Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.37K	Hold	371	–	–	﹤0.01%	931
2025 Q4	$5.28K	Hold	371	–	–	﹤0.01%	947
2025 Q3	$2.92K	Buy	371 +213	+135%	+$1.52K	﹤0.01%	1181
2025 Q2	$906	Sell	158 -3	-2%	-$19	﹤0.01%	1616
2025 Q1	$1.31K	Hold	161	–	–	﹤0.01%	1459
2024 Q4	$1.52K	Hold	161	–	–	﹤0.01%	1432
2024 Q3	$1.72K	Hold	161	–	–	﹤0.01%	1409
2024 Q2	$1.6K	Sell	161 -98	-38%	-$1.01K	﹤0.01%	1450
2024 Q1	$3.05K	Hold	259	–	–	﹤0.01%	1161
2023 Q4	$3.68K	Buy	259 +98	+61%	+$1.11K	﹤0.01%	1045
2023 Q3	$1.96K	Sell	161 -61	-27%	-$787	﹤0.01%	1278
2023 Q2	$2.79K	Hold	222	–	–	﹤0.01%	1129
2023 Q1	$2.46K	Hold	222	–	–	﹤0.01%	1142
2022 Q4	$2.71K	Hold	222	–	–	﹤0.01%	1123
2022 Q3	$2K	Hold	222	–	–	﹤0.01%	1101
2022 Q2	$2K	Buy	+222	New	+$1.83K	﹤0.01%	1140
2021 Q4	$1K	Sell	70 -50	-42%	-$557	﹤0.01%	1439
2021 Q3	$1K	Buy	+120	New	+$1.23K	﹤0.01%	1381

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Bell Investment Advisors's FOLD Position: Q1 2026 in Review

Bell Investment Advisors held its Amicus Therapeutics (FOLD) position steady in Q1 2026 at 371 shares worth $5.37K. The position accounts for ﹤0.01% of the portfolio, ranked #931.

Bell Investment Advisors first reported a position in FOLD in Q3 2021 and has held it in 18 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Bell Investment Advisors held 371 shares of Amicus Therapeutics worth $5.37K as of Q1 2026.
Bell Investment Advisors left its Amicus Therapeutics share count unchanged in Q1 2026.
Amicus Therapeutics made up ﹤0.01% of Bell Investment Advisors's portfolio in Q1 2026, its #931 holding.
Bell Investment Advisors first reported a position in Amicus Therapeutics in Q3 2021 and has held it in 18 quarters since.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Bell Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.